The proposed transaction involves the acquisition of 100 per cent shareholding of Bharat Serums and Vaccines Limited (BSV) by Mankind Pharma Ltd (Mankind).
A health-tech startup aimed to disrupt the industry of vitro fertilisation (IVF) treatment through AI-driven embryo selection ...
The presidential candidates have vastly divergent records on and plans for protecting access to reproductive health care, ...
In an official statement, the CCI said the proposed transaction involves the acquisition of 100% per cent shareholding of ...
Deal involves Mankind buying 100 per cent equity in Bharat Serums from PE firm Advent International at an enterprise value of ...
The research — one of the largest studies to date — is based on an analysis of more than 7.7 million births in Denmark, ...